BRIEF published on 07/29/2024 at 12:31, 2 months 10 days ago Sphene Capital Reaffirms 'Buy' Rating for Vidac Pharma Holding BUY Rating Cancer Therapy Sphene Capital Vidac Pharma VDA-1275
PRESS RELEASE published on 07/29/2024 at 12:26, 2 months 10 days ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Update report by Sphene Capital GmbH highlights promising results of VDA-1275 study by Vidac Pharma Holding Plc in cancer treatment. Buy recommendation maintained with EUR 4.90 target price Cancer Treatment Sphene Capital GmbH Vidac Pharma Holding VDA-1275 Study EUR 4.90 Target Price
BRIEF published on 06/12/2024 at 14:41, 3 months 26 days ago Vidac Pharma Holding Plc: Research Initiation by Sphene Capital GmbH with a Buy Rating Oncology BUY Rating Biopharmaceutical Clinical-stage Vidac Pharma
PRESS RELEASE published on 06/12/2024 at 14:36, 3 months 26 days ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Sphene Capital initiates coverage on Vidac Pharma Holding Plc with a Buy rating and a price target of EUR 4.90. Vidac Pharma focuses on reversing cancer cell metabolism for oncology treatments BUY Rating Sphene Capital GmbH Vidac Pharma Holding Plc Cancer Cell Metabolism Oncology Treatments
Published on 10/09/2024 at 01:25, 1 hour 47 minutes ago Pathfinder Announces Changes to Board of Directors
Published on 10/09/2024 at 01:15, 1 hour 57 minutes ago Organto Releases Fiscal 2023 Financial Results
Published on 10/09/2024 at 00:30, 2 hours 42 minutes ago Finexio Recognized in Spend Matters 2024 ‘50 Providers to Watch’ List
Published on 10/08/2024 at 22:15, 4 hours 57 minutes ago Reyna Silver Amends Terms of Medicine Springs Option Agreement
Published on 10/08/2024 at 22:10, 5 hours 2 minutes ago Gladstone Commercial Corporation Announces Monthly Cash Distributions for October, November and December 2024 and Earnings Release and Conference Call Dates for its Third Quarter Ended September 30, 2024
Published on 10/08/2024 at 20:57, 6 hours 15 minutes ago Creditor group responds to GZO’s incorrect statements
Published on 10/08/2024 at 18:28, 8 hours 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/08/2024 at 18:08, 9 hours 4 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 10/08/2024 at 17:45, 9 hours 27 minutes ago Affluent Medical Announces Participation in Upcoming Scientific Events
Published on 10/08/2024 at 17:45, 9 hours 27 minutes ago Affluent Medical Announces Participation in Upcoming Scientific Events.
Published on 10/08/2024 at 18:21, 8 hours 51 minutes ago Disclosure of the number of shares and the total number of voting rights as of September 30, 2024
Published on 10/08/2024 at 18:04, 9 hours 8 minutes ago Thales announces the distribution of an interim dividend and the reduction of its share capital by cancellation of treasury shares
Published on 10/08/2024 at 15:26, 11 hours 45 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 septembre 2024
Published on 10/08/2024 at 09:53, 17 hours 18 minutes ago Number of shares and voting rights - September 2024 (In French only)
Published on 10/08/2024 at 08:30, 18 hours 42 minutes ago Edenred invests in the Shift4Good fund to support the emergence of smarter, more responsible mobility